A detailed history of Wealthsource Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealthsource Partners, LLC holds 6,872 shares of GILD stock, worth $645,624. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,872
Previous 7,056 2.61%
Holding current value
$645,624
Previous $528,000 5.3%
% of portfolio
0.04%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$73.27 - $83.09 $13,481 - $15,288
-184 Reduced 2.61%
6,872 $556,000
Q3 2023

Nov 09, 2023

BUY
$73.94 - $80.67 $3,179 - $3,468
43 Added 0.61%
7,056 $528,000
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $123,972 - $141,407
-1,631 Reduced 18.87%
7,013 $540,000
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $9,277 - $10,569
120 Added 1.41%
8,644 $717,000
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $85,191 - $122,305
-1,367 Reduced 13.82%
8,524 $731,000
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $30,365 - $34,685
510 Added 5.44%
9,891 $610,000
Q2 2022

Aug 10, 2022

SELL
$57.72 - $65.01 $18,412 - $20,738
-319 Reduced 3.29%
9,381 $580,000
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $521 - $653
9 Added 0.09%
9,700 $577,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $85,771 - $97,352
1,322 Added 15.8%
9,691 $704,000
Q3 2021

Nov 18, 2021

SELL
$67.69 - $73.03 $63,560 - $68,575
-939 Reduced 10.09%
8,369 $585,000
Q2 2021

Nov 18, 2021

BUY
$63.47 - $69.35 $324,268 - $354,309
5,109 Added 121.67%
9,308 $641,000
Q1 2021

Jun 21, 2021

SELL
$60.0 - $68.46 $144,960 - $165,399
-2,416 Reduced 36.52%
4,199 $271,000
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $23,679 - $26,981
418 Added 6.75%
6,615 $385,000
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $42,041 - $52,860
677 Added 12.26%
6,197 $391,000
Q2 2020

Aug 17, 2020

SELL
$72.34 - $84.0 $87,025 - $101,052
-1,203 Reduced 17.89%
5,520 $425,000
Q1 2020

May 12, 2020

SELL
$62.63 - $80.22 $59,122 - $75,727
-944 Reduced 12.31%
6,723 $503,000
Q4 2019

Feb 12, 2020

SELL
$61.62 - $67.78 $376,436 - $414,068
-6,109 Reduced 44.35%
7,667 $498,000
Q3 2019

Nov 15, 2019

SELL
$62.51 - $69.0 $31,442 - $34,707
-503 Reduced 3.52%
13,776 $873,000
Q2 2019

Aug 09, 2019

BUY
$61.87 - $69.38 $555,345 - $622,754
8,976 Added 169.26%
14,279 $965,000
Q1 2019

May 16, 2019

BUY
$62.53 - $70.05 $331,596 - $371,475
5,303 New
5,303 $345,000
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $207,496 - $229,736
-2,911 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $188,865 - $220,304
2,911 New
2,911 $206,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wealthsource Partners, LLC Portfolio

Follow Wealthsource Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.